Provided by Tiger Trade Technology Pte. Ltd.

ABVC BioPharma, Inc.

0.7999
-0.0401-4.77%
Post-market: 0.79990.00000.00%16:10 EDT
Volume:76.00K
Turnover:62.31K
Market Cap:21.32M
PE:-2.80
High:0.8619
Open:0.8260
Low:0.7813
Close:0.8400
52wk High:3.40
52wk Low:0.7813
Shares:26.65M
Float Shares:21.83M
Volume Ratio:0.88
T/O Rate:0.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2855
EPS(LYR):-0.3933
ROE:-69.86%
ROA:-22.85%
PB:2.07
PE(LYR):-2.03

Loading ...

Nov 15, 2021

Statement Of Changes In Beneficial Ownership

3 - Initial statement of beneficial ownership of securities
Oct 08, 2021

Major Issues Report

8-K - Current report
Aug 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2021

Major Issues Report

8-K - Current report
Jul 29, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jul 29, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jul 29, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jul 28, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jul 21, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jun 21, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jun 08, 2021

Major Issues Report

8-K/A [Amend] - Current report
May 14, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 03, 2021

Major Issues Report

8-K/A [Amend] - Current report
Apr 08, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Mar 16, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 11, 2021

Major Issues Report

8-K - Current report
Jan 08, 2021

Major Issues Report

8-K - Current report
Jan 07, 2021

Major Issues Report

8-K - Current report
Dec 22, 2020

Correspondence

CORRESP [Cover] - Correspondence